Effects of methyl mercury on cytokines, inflammation and virus clearance in a common infection (coxsackie B3 myocarditis)

Toxicology Letters
Nils-Gunnar IlbäckG Friman

Abstract

A myocarditic coxsackievirus B3 (CB3) infection in Balb/c mice was used to investigate the effects of 12 weeks of methyl mercury (MeHg) exposure (3.69 mg/g diet) on inflammatory heart lesions, virus in the heart, the cytokine response, i.e. cachectin/TNF-alpha and gamma-interferon (IFN-gamma) levels in plasma, and on disease complications and mortality. This dose of MeHg did not influence mortality in this infection model. The inflammatory and necrotic lesions in the ventricular myocardium 7 days after the inoculation covered 2.2% of the tissue section area in infected control mice. This damage was increased (n.s.) by 50% (to 3.3% of the tissue section area) in MeHg-treated mice. The response pattern of lymphocyte subsets in situ in myocardial inflammatory lesions was corroborated using an immune histological technique. MeHg treatment tended to increase (2.2-fold, n.s.) the number of Mac 2+ cells (macrophages) in the heart muscle in this infection. Plasma levels of both TNF-alpha and IFN-gamma increased on day 3 of the infection in MeHg-treated as well as in non-MeHg-treated mice, but the mean IFN-gamma response was more pronounced in the MeHg-treated mice. On day 7 of the infection, when most animals still showed clinical sign...Continue Reading

References

May 1, 1992·Toxicology and Applied Pharmacology·N G IlbäckG Friman
Jan 1, 1992·Toxicology·N G IlbäckA W Glynn
Jun 1, 1990·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·J FohlmanS Huber
Jul 26, 1990·The New England Journal of Medicine·B LevineM Packer
Jan 1, 1985·Springer Seminars in Immunopathology·A G Johnson, J Regal
Mar 1, 1987·Reviews of Infectious Diseases·D A Tyrrell
Oct 1, 1989·Immunobiology·J N Ijzermans, R L Marquet
Dec 1, 1989·Current Opinion in Immunology·A Kelso
Feb 1, 1989·Current Opinion in Immunology·K J Tracey, A Cerami
Aug 1, 1988·Journal of Applied Toxicology : JAT·R Schoental
Jan 1, 1987·Critical Reviews in Toxicology·K Miura, N Imura
Oct 1, 1994·Biological Psychiatry·M Maes
Aug 1, 1994·The Journal of Infectious Diseases·M A BeckO A Levander
Aug 1, 1993·The Journal of General Virology·M TakekoshiY Watanabe
Dec 1, 1995·European Heart Journal·N G IlbäckG Friman
Oct 28, 1996·Toxicology·D AndersonJ A Hughes

❮ Previous
Next ❯

Citations

Oct 9, 1998·Biological Trace Element Research·N G IlbäckG Friman
Sep 24, 2009·Chemical Reviews·Reagan McRaeChristoph J Fahrni
Apr 10, 2009·The New England Journal of Medicine·Leslie T Cooper
Jun 15, 2007·Critical Reviews in Food Science and Nutrition·Nils-Gunnar Ilbäck, Göran Friman
Jun 24, 2008·Journal of Toxicology and Environmental Health. Part a·Tawit SuriyoJutamaad Satayavivad
Oct 11, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jennifer F NylandEllen K Silbergeld
Apr 14, 2010·Environmental Health Perspectives·Beth J FeingoldEllen K Silbergeld
Aug 5, 2003·Environmental Health Perspectives·Charles S ViaEllen K Silbergeld
Aug 28, 2009·Trends in Immunology·Michael Schiraldi, Marc Monestier
Apr 29, 2009·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Christina Nyström-RosanderNils-Gunnar Ilbäck
Aug 4, 2007·Congestive Heart Failure·Leslie T CooperNicholas V C Ralston
Sep 25, 2007·Environmental Research·Peter FriskNils-Gunnar Ilbäck
Mar 15, 2011·Environmental Research·Jennifer F NylandEllen K Silbergeld
Mar 23, 2015·Current Treatment Options in Cardiovascular Medicine·Antonio L Perez, W H Wilson Tang
Nov 8, 2014·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Kayla L PentaJennifer F Nyland
Jun 21, 2008·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Nils-Gunnar IlbäckGöran Friman
May 4, 2004·Environmental Health Perspectives·John H Weisburger
May 4, 2004·Environmental Health Perspectives·Steven Earl Salmony
May 4, 2004·Environmental Health Perspectives·Deborah Schoen
May 4, 2004·Environmental Health Perspectives·Lorenzo Tomatis
May 4, 2004·Environmental Health Perspectives·Ellen K Silbergeld
May 4, 2004·Environmental Health Perspectives·Jennifer B Sass, Herbert L Needleman
Jun 25, 2015·Carcinogenesis·Stephanie C CaseyDean W Felsher
Sep 4, 2008·Journal of Pharmacological and Toxicological Methods·Nils-Gunnar IlbäckGöran Friman
Jan 30, 2010·Progress in Cardiovascular Diseases·Lori A Blauwet, Leslie T Cooper

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.